Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment? by Sarah Beggiato, Mariachiara Zuccarini, Tommaso Cassano, Dasiel Oscar Borroto-Escuela, Patrizia Di Iorio, Robert Schwarcz, Kjell Fuxe, Luca Ferraro

Connect to this object online.

Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid by Korrapati V. Sathyasaikumar, Francesca M. Notarangelo, Deanna L. Kelly, Laura M. Rowland, Stephanie M. Hare, Shuo Chen, Chen Mo, Robert W. Buchanan, Robert Schwarcz

Connect to this object online.

Subchronic <i>N</i>-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice by Tonali Blanco Ayala, Daniela Ramírez Ortega, Paulina Ovalle Rodríguez, Benjamín Pineda, Gonzalo Pérez de la Cruz, Dinora González Esquivel, Robert Schwarcz, Korrapati V. Sathyasaikumar, Anabel Jiménez Anguiano, Verónica Pérez de la Cruz

Connect to this object online.

Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma by Korrapati V. Sathyasaikumar, Verónica Pérez de la Cruz, Benjamín Pineda, Gustavo Ignacio Vázquez Cervantes, Daniela Ramírez Ortega, David W. Donley, Paul L. Severson, Brian L. West, Flaviano Giorgini, Jonathan H. Fox, Robert Schwarcz

Connect to this object online.